Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis

被引:58
作者
Bee, Thomas [1 ]
Swiers, Gemma [1 ]
Muroi, Sawako [2 ]
Pozner, Amir [3 ]
Nottingham, Wade [1 ]
Santos, Ana Cristina [1 ]
Li, Pik-Shan [1 ]
Taniuchi, Ichiro [2 ]
de Bruijn, Marella F. T. R. [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England
[2] RCAI RIKEN, Lab Transcript Regulat, Kanagawa, Japan
[3] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
基金
英国医学研究理事会; 以色列科学基金会;
关键词
STEM-CELLS; DEFINITIVE HEMATOPOIESIS; ENDOTHELIAL-CELLS; MOUSE EMBRYO; HAEMOGENIC ENDOTHELIUM; ADULT HEMATOPOIESIS; HUMAN LEUKEMIA; FETAL LIVER; EXPRESSION; AML1;
D O I
10.1182/blood-2009-08-238626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The transcription factor Runx1 is a pivotal regulator of definitive hematopoiesis in mouse ontogeny. Vertebrate Runx1 is transcribed from 2 promoters, the distal P1 and proximal P2, which provide a paradigm of the complex transcriptional and translational control of Runx1 function. However, very little is known about the biologic relevance of alternative Runx1 promoter usage in definitive hematopoietic cell emergence. Here we report that both promoters are active at the very onset of definitive hematopoiesis, with a skewing toward the P2. Moreover, functional and morphologic analysis of a novel P1-null and an attenuated P2 mouse model revealed that although both promoters play important nonredundant roles in the emergence of definitive hematopoietic cells, the proximal P2 was most critically required for this. The nature of the observed phenotypes is indicative of a differential contribution of the P1 and P2 promoters to the control of overall Runx1 levels, where and when this is most critically required. In addition, the dynamic expression of P1-Runx1 and P2-Runx1 points at a requirement for Runx1 early in development, when the P2 is still the prevalent promoter in the emerging hemogenic endothelium and/or first committed hematopoietic cells. (Blood. 2010;115(15):3042-3050)
引用
收藏
页码:3042 / 3050
页数:9
相关论文
共 51 条
[1]   PEBP2-ALPHA-B/MOUSE AML1 CONSISTS OF MULTIPLE ISOFORMS THAT POSSESS DIFFERENTIAL TRANSACTIVATION POTENTIALS [J].
BAE, SC ;
OGAWA, E ;
MARUYAMA, M ;
OKA, H ;
SATAKE, M ;
SHIGESADA, K ;
JENKINS, NA ;
GILBERT, DJ ;
COPELAND, NG ;
ITO, Y .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) :3242-3252
[2]   Alternative Runx1 promoter usage in mouse developmental hematopoiesis [J].
Bee, Thomas ;
Liddiard, Kate ;
Swiers, Gemma ;
Bickley, Sorrel R. B. ;
Vink, Chris S. ;
Jarratt, Andrew ;
Hughes, Jim R. ;
Medvinsky, Alexander ;
de Bruijn, Marella F. T. R. .
BLOOD CELLS MOLECULES AND DISEASES, 2009, 43 (01) :35-42
[3]   The mouse Runx1+23 hematopoietic stem cell enhancer confers hematopoietic specificity to both Runx1 promoters [J].
Bee, Thomas ;
Ashley, Emma L. K. ;
Bickley, Sorrel R. B. ;
Jarratt, Andrew ;
Li, Pik-Shan ;
Sloane-Stanley, Jackie ;
Goettgens, Berthold ;
de Bruijn, Marella F. T. R. .
BLOOD, 2009, 113 (21) :5121-5124
[4]   Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation [J].
Ben Aziz-Aloya, R ;
Levanon, D ;
Karn, H ;
Kidron, D ;
Goldenberg, D ;
Lotem, J ;
Polak-Chaklon, S ;
Groner, Y .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (09) :765-773
[5]   A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis [J].
Ben-Ami, Oren ;
Pencovich, Niv ;
Lotem, Joseph ;
Levanon, Ditsa ;
Groner, Yoram .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (01) :238-243
[6]   Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo [J].
Cai, ZL ;
de Bruijn, M ;
Ma, XQ ;
Dortland, B ;
Luteijn, T ;
Downing, JR ;
Dzierzak, E .
IMMUNITY, 2000, 13 (04) :423-431
[7]   Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter [J].
Chen, Michael J. ;
Yokomizo, Tomomasa ;
Zeigler, Brandon M. ;
Dzierzak, Elaine ;
Speck, Nancy A. .
NATURE, 2009, 457 (7231) :887-891
[8]   The functional consequences of alternative promoter use in mammalian genomes [J].
Davuluri, Ramana V. ;
Suzuki, Yutaka ;
Sugano, Sumio ;
Plass, Christoph ;
Huang, Tim H. -M. .
TRENDS IN GENETICS, 2008, 24 (04) :167-177
[9]   Core-binding factors in hematopoiesis and immune function [J].
de Bruijn, MFTR ;
Speck, NA .
ONCOGENE, 2004, 23 (24) :4238-4248
[10]   Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta [J].
de Bruijn, MFTR ;
Ma, XQ ;
Robin, C ;
Ottersbach, K ;
Sanchez, MJ ;
Dzierzak, E .
IMMUNITY, 2002, 16 (05) :673-683